Senti Biosciences PT Lowered to 8.00 at Chardan Capital

SNTI Stock  USD 3.24  0.08  2.41%   
Under 56% of Senti Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that many traders are alarmed. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
Senti Biosciences had its price objective cut by Chardan Capital from 12.00 to 8.00 in a report issued on Friday, The Fly reports. They currently have a buy rating on the stock. Other equities analysts also recently issued reports about the stock. Bank of America started coverage on shares of Senti

Read at thelincolnianonline.com
news
  

Senti Biosciences Current Investor Sentiment

Comfort Level 44

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Senti Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Senti Biosciences.

Senti Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Senti Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Senti Biosciences Historical Investor Sentiment

Investor biases related to Senti Biosciences' public news can be used to forecast risks associated with an investment in Senti. The trend in average sentiment can be used to explain how an investor holding Senti can time the market purely based on public headlines and social activities around Senti Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Senti Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Senti Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Senti Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Senti Biosciences.

Senti Biosciences Fundamental Analysis

We analyze Senti Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Senti Biosciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Senti Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Senti Biosciences stock to make a market-neutral strategy. Peer analysis of Senti Biosciences could also be used in its relative valuation, which is a method of valuing Senti Biosciences by comparing valuation metrics with similar companies.

Peers

Senti Biosciences Related Equities

FHTXFoghorn Therapeutics   13.53   
0%
100.0%
MNPRMonopar Therapeutics   12.48   
0%
92.0%
TYRATyra Biosciences   9.20   
0%
67.0%
XLOXilio Development   8.19   
0%
60.0%
FENCFennec Pharmaceuticals   7.49   
0%
55.0%
MLYSMineralys Therapeutics,   5.76   
0%
42.0%
QNRXQuoin Pharmaceuticals   5.06   
0%
37.0%
SABSSAB Biotherapeutics   2.96   
0%
21.0%
LIPOLipella Pharmaceuticals   2.07   
0%
15.0%
CINGCingulate   1.78   
0%
13.0%
CNTBConnect Biopharma   1.55   
0%
11.0%
RAPTRAPT Therapeutics     
0%
1.0%
CVKDCadrenal Therapeutics,   2.27   
16.0%
0%

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account